Skip to contentM
Merit Medical Systems Inc
M
MMSIMerit Medical Systems Inc Q2 2024 · 10-Q
Revenue$338.00M$338.00M+5.6% vs Q2 2023 Net Income$35.73M$35.73M+76.5% vs Q2 2023 EPS Diluted$0.61$0.61+74.3% vs Q2 2023 Gross Profit$161,100,000+5.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Merit Medical Systems Inc · CIK 856982 · Engraved from SEC EDGAR
Operating Cash Flowderived$68,506,000+296.3% Free Cash Flowderived$57,879,000+402.6% Margins · derivedGross margin47.7%−0.1 pt vs Q2 2023
Operating margin13.6%+4.6 pt vs Q2 2023
Net margin10.6%+4.2 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 1, 2024 · 32 d after period end